Effect of flosequinan (BTS 49465) on myocardial oxygen consumption
- 1 June 1990
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 119 (6), 1355-1366
- https://doi.org/10.1016/s0002-8703(05)80186-3
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Flosequinan in heart failure: acute haemodynamic and longer term symptomatic effects.BMJ, 1988
- Hemodynamic effects of BTS 49465, a new long-acting systemic vasodilator drug, in patients with severe congestive heart failureAmerican Heart Journal, 1987
- The Role of Novel Inotropic Agents in the Treatment of Heart FailureJournal of Cardiovascular Pharmacology, 1986
- The Effect of the Cardiotonic Imazodan (CI-914) on Myocardial and Peripheral Hemodynamics in the Anesthetized DogJournal of Cardiovascular Pharmacology, 1986
- Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failureJournal of the American College of Cardiology, 1986
- Immediate effects of milrinone on metabolic and sympathetic responses to exercise in severe congestive heart failureThe American Journal of Cardiology, 1985
- Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.Circulation, 1985
- A Randomised Study of the Haemodynamic Changes Induced by Venodilatation and Arteriolar Dilatation Singly and Together in Left Ventricular Failure Complicating Acute Myocardial InfarctionJournal of Cardiovascular Pharmacology, 1984
- Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure.Circulation, 1977
- Control of myocardial oxygen consumptionThe American Journal of Cardiology, 1971